Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

26. April 2023 12:15 ET | Quelle: Aridis Pharmaceuticals, Inc.

Aridis Pharmaceuticals Receives Nasdaq Notice on Late Filing of its Form 10-K

LOS GATOS, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) (“Aridis” or the “Company”), a biopharmaceutical company, announced today that it received a notice...
31. März 2023 19:00 ET | Quelle: Aridis Pharmaceuticals, Inc.

Aridis Provides Corporate Update

LOS GATOS, Calif., March 31, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) (“Aridis” or the “Company”), a biopharmaceutical company, today announced a corporate update on...
25. Januar 2023 16:05 ET | Quelle: Aridis Pharmaceuticals, Inc.

Aridis Reports Top-Line Results of the Phase 3 Double-Blinded, Superiority Trial of AR-301 For the Treatment of Staphylococcus aureus Ventilator Associated Pneumonia (VAP)

LOS GATOS, Calif, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) today announced top-line results from the AR-301-002 Phase 3 study, which evaluated the superiority of...
03. August 2021 09:30 ET | Quelle: Research Dive

The Global Pneumonia Therapeutics Market Estimated to Generate a Revenue of $3,147.7 Million by 2027, Growing at a CAGR of 8.2% From 2020-2027 – Informative Report [230 Pages] by Research Dive

New York, USA, Aug. 03, 2021 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global pneumonia therapeutics market is expected to generate a revenue of $3,147.7 million by...
18. Mai 2021 07:00 ET | Quelle: Avisa Diagnostics Inc.

Avisa Diagnostics Begins Trading on the Canadian Securities Exchange

Public Listing offers Access to CAD 52 Million from Share Subscription and Drawdown Agreement, Sufficient Funding to Complete Development and Launch Avisa BreathTest™Pivotal Trials Planned in...